Back to
Janus Henderson Group Ltd.
AKROShowing 6 of 27 quarters
Position history for
Janus Henderson Group Ltd.'s holdings in AKERO THERAPEUTICS INC
As of its Q3 2025 13F, Janus Henderson held 6,280,305 shares of AKRO (Akero Therapeutics), worth $298.2M. Janus Henderson's 13F filings listed AKRO from Q2 2019 to Q3 2025, 26 quarterly filings. AKRO was 0.1% of Janus Henderson's reported 13F portfolio.
Final Value
$0
Final Shares
0
Total Value Change
-$203.1M
Total Shares Change
-7.1M
Quarter-by-Quarter History
Other major holders of AKRO: BlackRock, Inc., RTW INVESTMENTS, LP